See the DrugPatentWatch profile for Losartan
Losartan potassium active pharmaceutical ingredient (API) manufacturers in India are key suppliers in the global market. These companies produce the raw material used in the formulation of Losartan potassium medications, a widely prescribed drug for hypertension and heart failure.
Who are the main Losartan potassium API manufacturers in India?
Several Indian pharmaceutical companies are involved in the manufacturing of Losartan potassium API. These include companies like Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, and Lupin Limited, among others. These manufacturers adhere to stringent quality control measures to ensure the API meets international standards for safety and efficacy.
What quality standards do Indian Losartan potassium API manufacturers follow?
Indian API manufacturers for Losartan potassium typically comply with Good Manufacturing Practices (GMP) as stipulated by regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Indian regulatory authorities. Certifications from these bodies are crucial for exporting the API to regulated markets.
How does the patent status affect Losartan potassium API manufacturing?
The patent status of Losartan potassium has evolved over time. Original patents for Losartan potassium have expired in many major markets, opening the door for generic drug manufacturers. This expiration has led to increased competition among API manufacturers and a subsequent decrease in API prices. Information on patent expirations and related exclusivity periods can be found on DrugPatentWatch.com [1].
What are the regulatory requirements for importing Losartan potassium API into other countries?
Importing Losartan potassium API into countries like the United States or European nations requires manufacturers to submit detailed Drug Master Files (DMFs) to the respective regulatory agencies. These filings contain comprehensive information about the manufacturing process, quality control, and specifications of the API. Approval of these filings is necessary before the API can be used in finished drug products in those regions.
How do Indian Losartan potassium API prices compare globally?
Due to the competitive landscape and the large-scale manufacturing capabilities in India, Losartan potassium API is generally available at competitive prices globally. The expiration of patents has further driven down costs, making it a more accessible API for pharmaceutical companies worldwide.
What is the market outlook for Losartan potassium API from India?
The market for Losartan potassium API from India is expected to remain strong, driven by the continued demand for hypertension medications globally. Indian manufacturers are well-positioned to meet this demand due to their established infrastructure, expertise, and cost-effectiveness. The growth in generic drug markets, particularly in emerging economies, also contributes to the sustained demand for Indian-manufactured Losartan potassium API.
Where can I find more information on Losartan potassium patents and market exclusivity?
DrugPatentWatch.com provides detailed information on drug patents, including Losartan potassium, and helps track patent expiries and market exclusivity periods, which is vital for understanding the competitive landscape for API manufacturers [1].
---
Sources
[1] https://drugpatentwatch.com/